Beyond the Case Count: Lessons from Measles in South Carolina and Utah - On-Demand

This activity will provide healthcare professionals with an overview of measles pathophysiology, transmission, and historical significance, while examining factors contributing to its recent resurgence. Participants will review epidemiologic trends from recent outbreaks in South Carolina and Utah, including population risk factors and public health response efforts. The program will also explore current approaches to measles management, infection prevention strategies, and operational readiness considerations for healthcare organizations, highlighting the roles of pharmacists and pharmacy technicians in supporting patient care and health system preparedness.

Target Audience

Pharmacists
Pharmacy Technicians
Other Healthcare Professionals

Learning Objectives

At the conclusion of this activity, pharmacists should be able to:

Review the pathophysiology and historical context of measles, including transmission dynamics, disease progression, and factors contributing to its re-emergence.
Analyze the epidemiology of recent measles outbreaks in South Carolina and Utah, with a focus on case trends, population risk factors, and public health response efforts.
Discuss current therapeutic approaches and operational readiness strategies for managing measles patients, including infection prevention, clinical management, and health system preparedness.

At the conclusion of this activity, pharmacy technicians should be able to:

Describe the basic pathophysiology, transmission, and epidemiology of measles, including key trends observed in recent outbreaks in South Carolina and Utah.
Identify and support pharmacy technician roles in the management of measles patients, including medication handling, infection prevention practices, and operational readiness within healthcare settings.

Course summary

Available credit:

1.00 ACPE Pharmacist
1.00 ACPE Pharmacy Technician
1.00 General CE - Attendance

Course opens:

07/24/2026

Course expires:

07/23/2027

FACULTY & PLANNERS

Faculty

Krutika Mediwala Hornback, PharmD, BCIDP
System Pharmacy Coordinator – Antimicrobial Stewardship -Clinical Pharmacy Specialist – Infectious Diseases/Antimicrobial Stewardship
Residency Program Director, PGY2 Infectious Diseases Residency
MUSC Health

Rachel Ronne, MPH
MUSC Enterprise Occupational Epidemiology - MUSC Health System Quality & Safety - MUSC Health System Infection Prevention & Control
MUSC Health

Darrell Childress, PharmD, BCPS, BCIDP
Advanced Infectious Diseases/Antimicrobial Stewardship Pharmacist
Intermountain Health

Planners

Stacy Lauderdale, PharmD, BCPS
AVP, Evidence-Based Medicine
Vizient, Inc.

John Schoen, PharmD, BCPS
Pharmacy Executive III
Vizient, Inc.

Jackie Stokes
Program Service Manager
Vizient, Inc.

Kim Bentley, CHCP

CE Programs Manager

Vizient, Inc.

Marilu Kelly, MSN, RN, NPD-BC, CHCP

Director, Continuing Education

Vizient, Inc.

DISCLOSURE

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

Statement of Content Validity

Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.

FDA Off-Label Use

Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.

Disclaimer

The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

Disclosure Statements

Relevant Financial Relationships

Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

All relevant financial relationships listed for these individual(s) have been mitigated.

All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Course Director(s)